Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Cash from Investing Activities (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed Cash from Investing Activities for 16 consecutive years, with -$16.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities rose 90.32% to -$16.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$64.9 million, a 67.55% increase, with the full-year FY2025 number at -$64.9 million, up 67.55% from a year prior.
  • Cash from Investing Activities was -$16.8 million for Q4 2025 at Lemaitre Vascular, up from -$27.4 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of -$402000.0 in Q4 2022 to a low of -$173.9 million in Q4 2024.
  • A 5-year average of -$18.1 million and a median of -$7.9 million in 2021 define the central range for Cash from Investing Activities.
  • Peak YoY movement for Cash from Investing Activities: surged 97.58% in 2021, then tumbled 7590.93% in 2024.
  • Lemaitre Vascular's Cash from Investing Activities stood at -$7.2 million in 2021, then soared by 94.45% to -$402000.0 in 2022, then plummeted by 462.44% to -$2.3 million in 2023, then crashed by 7590.93% to -$173.9 million in 2024, then skyrocketed by 90.32% to -$16.8 million in 2025.
  • Per Business Quant, the three most recent readings for LMAT's Cash from Investing Activities are -$16.8 million (Q4 2025), -$27.4 million (Q3 2025), and -$16.3 million (Q2 2025).